xbrl.rienks.biz
English 
Nederlands
Français
Deutsch Fornix BioSciences N.V.
| Address | Exchange | Stocks (09-02-2012: 17:25:00) | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
4.84%Industry: Health Care
Sector: Biotechnology
Companies engaged in research into and development of biological substances for the purposes of drug discovery and diagnostic development, and which derive the majority of their revenue from either the sale or licensing of these drugs and diagnostic tools.
| Crucell N.V. | (CRXL) | Biotechnology |
| Fornix BioSciences N.V. | (FORBI) | Biotechnology |
| Galapagos | (GLPGA) | Biotechnology |
| Pharming Group N.V. | (PHARM) | Biotechnology |
| English | Dutch | |
| Annual Report 2007 (11.84 MB) (KPMG) Annual Report 2006 (4.38 MB) (KPMG) Annual Report 2005 (2.97 MB) (KPMG) Annual Report 2004 (3.38 MB) (KPMG) Annual Report 2003 (2.66 MB) (KPMG) Annual Report 2002 (3.37 MB) (KPMG) | Jaarverslag 2007 (11.23 MB) (KPMG) Jaarverslag 2006 (4.28 MB) (KPMG) Jaarverslag 2005 (2.91 MB) (KPMG) Jaarverslag 2004 (3.62 MB) (KPMG) Jaarverslag 2003 (2.67 MB) (KPMG) Jaarverslag 2002 (3.53 MB) (KPMG) |
News
| Ambit Biosciences to Present at Two Upcoming Investor Conferences (09 Feb)
SAN DIEGO, Feb. 9, 2012 /PRNewswire/ -- Ambit Biosciences today announced that Michael A. Martino, Ambit's president and chief executive officer, will provide an overview of the company and an update about ..... Sangamo BioSciences Announces Presentation at 2012 Leerink Swann Global Healthcare Conference (09 Feb)RICHMOND, Calif., Feb. 9, 2012 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO - News) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress of Sangamo's ..... Ardea Biosciences to Present at Upcoming Investor Conferences (08 Feb)SAN DIEGO, CA-- - Ardea Biosciences, Inc. announced today that Barry D. Quart, PharmD, president and chief executive officer, will present at the following upcoming investor conferences in February 2012:Leerink ..... | Neurocrine Biosciences Shares Dropped: What You Need to Know (09 Feb)
Is this meaningful? Or just another movement?.. Precision BioSciences Announces Allowance of Fourth U.S. Patent Related to Engineered Meganucleases (02 Feb)Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that the United States Patent and Trademark Office has issued a Notice of Allowance for U.S... Pacific Biosciences of California, Inc. Announces Financial Results for the Fourth Quarter and Year Ended December 31 ... (07 Feb)MENLO PARK, Calif. -- Pacific Biosciences of California, Inc. today announced financial results for the fourth quarter and the year ended December 31, 2011... |
Financial Calendar
| Yearly result | Quaterly Results | Analyst & Investor Conference |
|---|---|---|
| 16-03-2006 | Q1 - | - |
| Q2 14-08-2006 | - | |
| AGM | Q3 - | - |
| - | Q4 - | - |
Annual Accounts Fornix BioSciences N.V.